ReviewNeuro-oncology advances

Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail.

Zachariah P Tritz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.